Activation of virus replication after vaccination of HIV-1-infected individuals

Journal of Experimental Medicine

Volumn 182, Issue 6, 1995, Pages 1727-1737

  Staprans, Silvija I ^a   Hamilton, Brian L ^a   Follansbee, Stephen E ^b,c   Elbeik, Tarek ^d,e   Barbosa, Peter ^d,e   Grant, Robert M ^a,f   Feinberg, Mark B ^a,c,d,e  

^a GLADSTONE INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c Bay Area Community Consortium ^*  (United States)

^d San Francisco CenterforAIDS Research Virology Laboratory ^*  (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VACCINATION; VIRUS ACTIVATION; VIRUS REPLICATION;

ADULT; ANTIBODIES, VIRAL; HIV INFECTIONS; HUMAN; IMMUNOPHENOTYPING; INFLUENZA VACCINE; LYMPHOCYTE ACTIVATION; POLYMERASE CHAIN REACTION; RNA, VIRAL; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; TIME FACTORS; VACCINATION; VIRUS REPLICATION;

EID: 0028871397     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.182.6.1727     Document Type: Article

References (54)

1. Lewis, P., M. Hensel, and M. Emerman. 1992. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO (Eur. Mol. Biol. Organ.)J. 11: 3053-3058.
2. Stevenson, M., T. Stanwick, M. Dempsey, and C. Lamonica. 1990. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO (Eur. Mol. Biol. Organ.) J. 9: 1551-1560.
3. Zack, J., S. Arrigo, S. Weitsman, A. Go, A. Haislip, and I. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell. 61: 213-222.
4. Baeuerle, P., and T. Henkel. 1994. Function and activation ofNF-kappa B in the immune system. Annu. Rev. Immunol. 12: 141-179.
5. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function ofNF-kappa B. Annu. Rev. Cell Biol. 10: 405-455.
6. Fauci, A. 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science (Wash. DC). 262: 1011-1018.
7. Cheynier, R., S. Henrichwark, F. Hadida, E. Pelletier, E. Oksenhendler, B. Autran, and S. Wain-Hobson. 1994. HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes. Cell. 78: 373-387.
8. Embretson, J., M. Zupancic, J. Ribas, A. Burke, P. Racz, R. Tenner, and A. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (Land.). 362: 359-362.
9. Pantaleo, G., C. Graziosi, J. Demarest, L. Butini, M. Montroni, C. Fox, J. Orenstein, D. Kotler, and A. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (Lond.). 362: 355-358.
10. Coffin, J. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogensis, and therapy. Science (Wash. DC). 267: 483-489.
11. Ho, D., A. Neumann, A. Perelson, W. Chen, J. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (Lond.). 373: 123-126.
12. Wei, X., S. Ghosh, M. Taylor, V. Johnson, E. Emini, P. Deutsch, J. Lifson, S. Bonhoeffer, M. Nowak, B. Hahn, et al. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature (Lond.). 373: 117-122.
13. Schnittman, S., H. Lane, J. Greenhouse, J. Justement, M. Baseler, and A. Fauci. 1990. Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc. Natl. Acad. Sci. USA. 87: 6058-6062.
14. Shearer, G., and M. Clerici. 1991. Early T-helper cell defects in HIV infection. AIDS (Phila.). 5: 245-253.
15. ACP Task Force on Adult Immunization and Infectious Diseases Society of America. 1994. Guide for Adult Immunization. American College of Physicians, Philadelphia, PA.
16. Prevention and control of influenza: part I, vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). 1993. Morb. Mortal. Wkly. Rep. 43: 1-14.
17. Poland, G., K. Love, and C. Hughes. 1990. Routine immunization of the HIV-positive asymptomatic patient. J. Gen. Intern. Med. 5: 147-152.
18. Nelson, K., M. Clements, P. Miotti, S. Cohn, and B. Polk. 1988. The influence of human immunodeficiency vims (HIV) infection on antibody responses to influenza vims. Ann. Intern. Med. 109: 383-388.
19. Ho, D. 1992. HIV-1 viraemia and influenza. Lancet. 339: 1549.
20. Fultz, P., J. Gluckman, E. Muchmore, and M. Girard. 1992. Transient increases in numbers of infectious cells in an HIVinfected chimpanzee following immune stimulation. AIDS Res. Hum. Retroviruses. 8: 313-317.
21. Clements, M., and B. Murphy. 1986. Development and persistence of local and systemic antibody responses in adults given live and inactivated influenza A vaccine. J. Clin. Microbiol. 23: 66-72.
22. The AIDS Clinical Trials Group Virology Technical Advisory Committee and the Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health. 1994. ACTG Virology Manual for HIV Laboratories. U.S. Department of Health and Human Services, National Institutes of Health and Human Services, National Institutes of Health, Washington, D.C. 1-2.
23. Pachl, C., J. Todd, D. Kern, P. Sheridan, S. Fong, M. Stempien, B. Hoo, D. Besemer, T. Yeghiazarian, B. Irvine, et al. 1995. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA (bDNA) signal amplification assay. J. AIDS. 8: 446-454.
24. Piatak, M., K. Luk, B. Williams, and J. Lifson. 1993. Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. Biotechniques. 14: 70-81.
25. Piatak, M., M. Saag, L. Yang, S. Clark, J. Kappes, K. Luk, B. Hahn, G. Shaw, andj. Lifson. 1993. High levels ofHIV-1 in plasma during all stages of infection determined by competitive PCR. Science (Wash. DC). 259: 1749-1754.
26. Coligan, J., A. Kmisbeek, D. Margulies, E. Shevach, and W. Strober, editors. Current Protocols in Immunology. 1991. Greene Publishing Associates/Wiley-Interscience, New York. 3.12.1-5.4.13.
27. Washington, J.A., editor. 1985. Laboratory Procedures in Clinical Microbiology. 2nd edition. Springer-Verlag, New York. 125-137.
28. Kendal, A., W. Dowdle, and G. Noble. 1985. Influenza viruses. In Manual of Clinical Microbiology, 4th edition. E.H. Lennette, editor. American Society for Microbiology, Washington, D.C. 755-762.
29. Cao, Y. D. Ho, J. Todd, R. Kokka, M. Urdea, J. Lifson, M. Piatak, S. Chen, B. Hahn, M. Saag, and G. Shaw. 1995. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS. Res. Hum. Retroviruses. 11: 353-361.
30. Dewar, R., H. Highbarger, M. Sarmiento, J. Todd, M. Vasudevachari, R. Davey, J. Kovacs, N. Salzman, H. Lane, and M. Urdea. 1994. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J. Infect. Dis. 170: 1172-1179.
31. Fauci, A., and H. Lane. 1994. Human immunodeficiency virus (HIV) disease: AIDS and related disorders. In Harrison’s Principles of Internal Medicine, 13th ed. K. Isselbacher, E. Braunwald, J. Wilson, J. Martin, A. Fauci, and D. Kasper, editors. McGraw-Hill, New York. 1566-1618.
32. Hadler, S., F. Judson, P. O’Malley, N. Altman, K. Penley, S. Buchbinder, C. Schable, P. Coleman, D. Ostrow, and D. Francis. 1991. Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J. Infect. Dis. 163: 454-459.
33. Pape, J., S. Jean, J. Ho, A. Hafner, and W. Johnson. 1993. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet. 342: 268-272.
34. Stein, D., N. Graham, L. Park, D. Hoover, J. Phair, R. Detels, M. Ho, and A. Saah. 1994. The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort Study. Ann. Intern. Med. 121: 100-108.
35. Kovacs, J., M. Baseler, R. Dewar, S. Vogel, R. Davey, J. Falloon, M. Polis, R. Walker, R. Stevens, and N. Salzman. 1995. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. N. Engl. J. Med. 332: 567-575.
36. Cox, R., K. Brokstad, M. Zuckerman, J. Wood, L. Haaheim, andj. Oxford. 1994. An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine. 12: 993-999.
37. Brokstad, K., R. Cox, J. Olofsson, R. Jonsson, and L. Haaheim. 1995. Parenteral influenza vaccination induces a rapid systemic and local immune response. J. Infect. Dis. 171: 198-203.
38. Mitchell, D., P. Fitzharris, R. Knight, and G. Schild. 1982. Kinetics of specific in vitro antibody production following influenza immunization. Clin. Exp. Immunol. 48: 491-498.
39. Couch, R., and J. Kasel. 1983. Immunity to influenza in man. Annu. Rev. Microbiol. 37: 529-549.
40. Unutmaz, D., P. Pileri, and S. Abrignani. 1994. Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J. Exp. Med. 180: 1159-1164.
41. Grossman, Z., and W. Paul. 1992. Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses. Proc. Natl. Acad. Sci. USA. 89: 10365-10369.
42. Carding, S., W. Allan, A. McMickle, and P. Doherty. 1993. Activation of cytokine genes in T cells during primary and secondary murine influenza pneumonia. J. Exp. Med. 177: 475-482.
43. Rose, D., C. Schechter, and H. Sacks. 1993. Influenza and pneumococcal vaccination of HIV-infected patients: a policy analysis. Am. J. Med. 94: 160-168.
44. Jewett, J., and F. Hecht. 1993. Preventive health care for adults with HIV infection. JAMA. 269: 1144-1153.
45. Kroon, F., J. van Dissel, J. de Jong, and R. van Furth. 1994. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS. 8: 469-476.
46. Miotti, P., K. Nelson, G. Dallabetta, H. Farzadegan, J. Margolick, and M. Clements. 1989. The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine. JAMA. 262: 779-783.
47. Ragni, M., F. Ruben, A. Winkelstein, J. Spero, F. Bontempo, andj. Lewis. 1987. Antibody responses to immunization of patients with hemophilia with and without evidence of human immunodeficiency virus (human T-lymphotropic virus type III) infection. J. Lab. Clin. Med. 109: 545-549.
48. Safrin, S., J. Rush, and J. Mills. 1990. Influenza in patients with human immunodeficiency virus infection. Chest. 98: 33-37.
49. Casadevall, A., J. Dobroszycki, C. Small, and L. Pirofski. 1992. Haemophilus influenzae type b bacteremia in adults with AIDS and at risk for AIDS. Am.J. Med. 92: 587-590.
50. Janoff, E., R. Breiman, C. Daley, and P. Hopewell. 1992. Pneumococcal disease during HIV infection. Epidemiologic, clinical, andimmunologic perspectives. Ann. Intern. Med. 117: 314-324.
51. Murphy, T. 1992. Haemophilus influenzae and viruses 100 years later: from influenza to human immunodeficiency virus. Am.J. Med. 92: 583-586.
52. Huang, K., F. Ruben, C. Rinaldo, L. Kingsley, D. Lyter, and M. Ho. 1987. Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. JAMA. 257: 2047-2050.
53. Weiss, P., M. Wallace, E. Oldfield, J. O’Brien, and E. Janoff. 1995. Response of recent human immunodeficiency virus seroconverters to the pneumococcal polysaccharide vaccine and haemophilus influenzae type b conjugate vaccine. J. Infect. Dis. 171: 1217-1222.
54. Conover, W., M. Johnson, and M. Johnson. 1981. A comparative study of tests for homogeneity of variances with applications to the outer continental shelf bidding data. Technometrics. 23: 351-361.